Pharmacological Chaperones and Coenzyme Q(10) Treatment Improves Mutant β-Glucocerebrosidase Activity and Mitochondrial Function in Neuronopathic Forms of Gaucher Disease

Gaucher disease (GD) is caused by mutations in the GBA1 gene, which encodes lysosomal β-glucocerebrosidase. Homozygosity for the L444P mutation in GBA1 is associated with high risk of neurological manifestations which are not improved by enzyme replacement therapy. Alternatively, pharmacological cha...

Descripción completa

Detalles Bibliográficos
Autores principales: de la Mata, Mario, Cotán, David, Oropesa-Ávila, Manuel, Garrido-Maraver, Juan, Cordero, Mario D., Villanueva Paz, Marina, Delgado Pavón, Ana, Alcocer-Gómez, Elizabet, de Lavera, Isabel, Ybot-González, Patricia, Paula Zaderenko, Ana, Ortiz Mellet, Carmen, Fernández, José M. García, Sánchez-Alcázar, José A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4456666/
https://www.ncbi.nlm.nih.gov/pubmed/26045184
http://dx.doi.org/10.1038/srep10903

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4456666/
https://www.ncbi.nlm.nih.gov/pubmed/26045184
http://dx.doi.org/10.1038/srep10903

Ejemplares similares